deltatrials
Completed OBSERVATIONAL NCT01394614

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Risk of Narcolepsy Associated With Administration of Inactivated Adjuvanted (AS03) A/H1N1 Pandemic Influenza Vaccine in Quebec

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Conditions Narcolepsy
Interventions A/H1N1 vaccine
Updated 13 times since 2017 Last updated: May 12, 2015 Started: Jun 30, 2011 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Narcolepsy, this trial is completed. The trial is conducted by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal and has accumulated 13 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshot~Jul 2025 – present · 13 months · monthly snapshot

Change History

13 versions recorded

  1. Jul 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Jul 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2023 — Jul 2024 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

▶ Show 8 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Completed

  2. Jan 2021 — Dec 2021 [monthly]

    Completed

  3. Nov 2020 — Jan 2021 [monthly]

    Completed

  4. Jun 2018 — Nov 2020 [monthly]

    Completed

  5. May 2018 — Jun 2018 [monthly]

    Completed

  6. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  7. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  8. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
  • GlaxoSmithKline
Data source: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations